Artichoke (Cynara scolymus)
Artichoke extract contains cynarin and chlorogenic acid that inhibit HMG-CoA reductase and enhance bile acid synthesis, supporting cardiovascular and liver health. Clinical trials demonstrate significant reductions in cholesterol levels, blood pressure, and liver enzymes in patients with metabolic conditions.

Origin & History
Artichoke (Cynara scolymus) is a perennial Mediterranean plant in the Asteraceae family, cultivated for its edible flower heads and medicinal leaves. The leaves are extracted using aqueous or hydroalcoholic methods to produce standardized extracts rich in phenolic compounds, flavonoids, and sesquiterpene lactones.
Historical & Cultural Context
Used since the 4th century BC by Aristotle's pupils for liver conditions, artichoke was valued by Egyptians as a health food and by Greeks and Romans as an elite digestive aid. European use from the 16th-19th centuries focused on jaundice, hepatitis, and fat metabolism, while Dioscorides documented it in De Materia Medica in the 1st century AD.
Health Benefits
• Reduces cholesterol levels (8-week RCT showed improvements in TC, HDL-C, LDL-C, and TC-to-HDL-C ratio) • Supports liver health and reduces liver enzymes in non-alcoholic steatohepatitis patients (2-month trial) • Lowers blood pressure in hypertensive individuals (8-week and 12-week trials) • Relieves digestive complaints including fullness and bloating (endorsed by HMPC/ESCOP) • Provides antioxidant and hepatoprotective effects (supported by clinical reviews)
How It Works
Artichoke's primary bioactive compounds cynarin and chlorogenic acid inhibit HMG-CoA reductase, the rate-limiting enzyme in cholesterol synthesis. These compounds also enhance bile acid production and secretion, promoting cholesterol elimination while improving hepatic lipid metabolism through modulation of SREBP-1c and PPAR-α pathways.
Scientific Research
Clinical trials have demonstrated artichoke leaf extract's effectiveness for hypercholesterolemia (8-week RCT), non-alcoholic steatohepatitis (2-month trial with six daily tablets), and hypertension (8-week powder capsule trial and 12-week juice trial). Meta-analyses support digestive benefits, and the HMPC and ESCOP recognize its use for dyspeptic complaints based on clinical evidence.
Clinical Summary
An 8-week randomized controlled trial demonstrated artichoke extract significantly improved total cholesterol, HDL-C, LDL-C, and TC-to-HDL-C ratios. A 2-month trial in non-alcoholic steatohepatitis patients showed reduced liver enzymes and improved hepatic function. Blood pressure studies spanning 8-12 weeks reported meaningful reductions in both systolic and diastolic pressure in hypertensive individuals, though larger trials are needed to confirm optimal dosing protocols.
Nutritional Profile
Artichoke (Cynara scolymus) per 100g edible portion (boiled hearts): Macronutrients: Calories ~53 kcal, Carbohydrates ~12g (of which inulin-type fructans 3–10g, a prebiotic fiber), Dietary fiber ~5.4g (predominantly insoluble cellulose and soluble inulin), Protein ~2.9g (containing essential amino acids including glutamine and aspartate), Fat ~0.2g. Micronutrients: Folate (B9) ~68 µg (17% DV), Vitamin C ~7.4 mg, Vitamin K ~14.8 µg, Vitamin B6 ~0.1 mg, Magnesium ~42 mg, Potassium ~354 mg, Phosphorus ~90 mg, Calcium ~21 mg, Iron ~1.3 mg, Zinc ~0.49 mg, Copper ~0.23 mg, Manganese ~0.26 mg. Bioactive Compounds: Cynarin (1,3-dicaffeoylquinic acid) ~50–80 mg/100g fresh weight (primary hepatoprotective and choleretic compound; heat-sensitive, partially degraded on cooking), Chlorogenic acid ~70–100 mg/100g (antioxidant; bioavailability ~30–40% as absorbed in small intestine and colonic fermentation), Luteolin and luteolin-7-O-glucoside ~3.5–10 mg/100g (flavones with anti-inflammatory activity; bioavailability enhanced by gut microbiota deglycosylation), Apigenin ~1–3 mg/100g, Cynaroside (luteolin-7-glucoside) as predominant flavonoid glycoside, Sesquiterpene lactones (cynaropicrin) ~0.5–1% dry weight in leaves (primary bitter principle; concentrated in leaf extracts rather than edible hearts). Inulin content (3–10g/100g) is notable for prebiotic activity with low glycemic impact; bioavailability of polyphenols is highest from standardized leaf extracts (standardized to ≥2.5–5% caffeoylquinic acids) compared to cooked vegetable. Cynarin and chlorogenic acids are best preserved in raw or minimally processed forms. Leaf extract preparations (e.g., 320–1800 mg/day in clinical trials) deliver significantly higher concentrations of bioactives than dietary consumption alone.
Preparation & Dosage
Clinically studied doses include artichoke leaf extract at two doses for 8 weeks (hypercholesterolemia), artichoke powder capsules twice daily for 8 weeks (hypertension), six tablets daily for 2 months (steatohepatitis), and concentrated juice for 12 weeks (blood pressure). Extracts are often standardized to cynarin or chlorogenic acid content. Consult a healthcare provider before starting any new supplement.
Synergy & Pairings
Milk thistle, dandelion, turmeric, alpha-lipoic acid, berberine
Safety & Interactions
Artichoke extract is generally well-tolerated with mild gastrointestinal upset reported in some users. Individuals with gallstones should avoid artichoke supplements as increased bile production may exacerbate symptoms. The extract may enhance the effects of cholesterol-lowering medications, requiring dosage adjustments. Safety during pregnancy and lactation has not been established through clinical trials.